Cascadia Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$3.73M Sell
6,535
-296
-4% -$162K 0.76% 30
2021
Q2
$3.45M Buy
6,831
+609
+10% +$287K 0.74% 30
2021
Q1
$2.84M Buy
+6,222
New +$2.97M 0.63% 40
2020
Q3
$2.69M Sell
6,088
-838
-12% -$346K 0.75% 26
2020
Q2
$2.51M Buy
+6,926
New +$2.32M 0.77% 22
2019
Q4
$2.08M Buy
+6,413
New +$1.94M 0.59% 46

Other funds holding TMO

Cascadia Advisory Services's TMO Position: Q3 2021 in Review

Cascadia Advisory Services reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q3 2021, selling an estimated $162K and leaving 6,535 shares worth $3.73M. The position accounts for 0.76% of the portfolio, ranked #30.

Cascadia Advisory Services first reported a position in TMO in Q4 2019 and has held it in 6 quarters since. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Cascadia Advisory Services held 6,535 shares of Thermo Fisher Scientific worth $3.73M as of Q3 2021.
  • Cascadia Advisory Services sold 296 Thermo Fisher Scientific shares in Q3 2021, an estimated $162K.
  • Thermo Fisher Scientific made up 0.76% of Cascadia Advisory Services's portfolio in Q3 2021, its #30 holding.
  • Cascadia Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 6 quarters since.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.